- Description
| Specificity Profile | More Information |
 | The specificity of CX3CL1 Monoclonal Antibody (CSB0111) was tested on the Membrane Proteome Array™ and shown to be specific for human CX3CL1. The Membrane Proteome Array™ contains 6,000 different human membrane proteins, each expressed in unfixed human cells to ensure native conformation and post-translational modifications. The Membrane Proteome Array™ represents the industry standard for determining the binding specificity of antibodies and other protein ligands. |
| Application | Conditions | Recommended Concentration |
| Flow Cytometry, Extracellular | Live, Unpermeabilized | 1 µg/ml |
 | HEK-293F cells transiently transfected with human CX3CL1 were stained with CX3CL1 Monoclonal Antibody (CSB0111) (green) or isotype control antibody (gray), followed by AlexaFluor 647-conjugated anti-Mouse IgG secondary antibody. HEK-293F cells transiently transfected with an empty control vector were also stained with CX3CL1 Monoclonal Antibody (CSB0111) (blue). | |
| Application | Conditions | Recommended Concentration |
| Immunofluorescence, Extracellular | Fixed 4% paraformaldehyde | 1 µg/ml |
 | (A) COS-7 cells transiently transfected with human CX3CL1 were stained with CX3CL1 Monoclonal Antibody (CSB0111) followed by AlexaFluor 647 anti-Mouse IgG secondary antibody (red) and DAPI (blue). (B) COS-7 cells transiently transfected with an empty control vector stained with CX3CL1 Monoclonal Antibody. (C) Isotype control: COS-7 cells transfected with human CX3CL1 and stained with control MAb. | |
| Application | Conditions | Recommended Concentration |
| Immunofluorescence, Intracellular | Fixed 4% paraformaldehyde, Permeabilized 0.1% Triton X-100 | 1 µg/ml |
 | (A) COS-7 cells transiently transfected with human CX3CL1 were permeabilized and stained with CX3CL1 Monoclonal Antibody (CSB0111) followed by AlexaFluor 647 anti-Mouse IgG secondary antibody (red) and DAPI (blue). (B) COS-7 cells transiently transfected with an empty control vector stained with CX3CL1 Monoclonal Antibody. (C) Isotype control: COS-7 cells transfected with human CX3CL1 and stained with control MAb. | |
CSB VeRSaMAbs:
We produce and validate all our monoclonal antibodies in-house so that you can confidently choose the right antibody for your assay. All antibodies are VALIDATED for common applications, RECOMBINANT for batch-to-batch consistency, and SPECIFIC in binding to only your target.
| Target | CX3CL1 |
| Target Aliases | Fractalkine, C3Xkine, ABCD-3, CXC3C, SCYD1, CXC3, NTN, NTT, FKN |
| Isotype | Mouse IgG2a |
| Membrane Proteome Specificity | Monospecific for 6,000 membrane proteins tested |
| Species Reactivity | Human (others untested) |
| Fc Modifications | C-terminal Avitag, disabled Fc-gamma receptor binding |
| Source | Recombinant CHO expression; purified by Protein A chromatography |
| Formulation | Endotoxin Free PBS pH 7.4, sterile-filtered |
| Concentration | 1 mg/ml |
Stable for 12 months from date of receipt when stored at 4°C. Avoid repeated freeze-thaw cycles.
CX3CL1 is a member of the CX3C subgroup of chemokines and exists as a single-pass transmembrane protein and as a soluble chemotactic chemokine. CX3CL1 binds CX3CR1, ITGAV:ITGB3, and ITGA4:ITGB1 and plays roles in immune response, inflammation, cell adhesion, and chemotaxis. CX3CL1 is involved in cancer, inflammatory diseases, HIV infection, vasculitis, atherosclerosis, and neuropathies. (NCBI Gene: 6376, UniProtKB/Swiss-Prot: P78423). Other names: Fractalkine, C3Xkine, ABCD-3, CXC3C, SCYD1, CXC3, NTN, NTT, FKN
